Management of Persistent Cough with Wheezing After Upper Respiratory Infection

Immediate Assessment and Interventions

The British Thoracic Society guidelines support oral steroids for moderately severe to severe episodes with wheezing and reduced activity 3, 4
The American College of Chest Physicians recommends against the use of expectorants like Mucinex in acute bronchitis or post-infectious cough 2
Improper inhaler technique is a common cause of treatment failure and must be excluded before escalating therapy, according to the Praxis Medical Insights 1
Oral corticosteroids are indicated for acute exacerbations when patients have respiratory rate >25/min, cannot complete sentences, or have persistent symptoms despite bronchodilator use 3, 4

Benzonatate can be prescribed for short-term symptomatic relief of cough, but only after addressing the underlying bronchospasm and inflammation, as recommended by the Chest guidelines 2, 5
The American College of Chest Physicians explicitly states there is no proven benefit for expectorants in chronic bronchitis or acute exacerbations 2

The British Thoracic Society guidelines recommend switching to nebulized albuterol 5 mg (or 2.5 mg if using unit-dose vials) every 4-6 hours for acute exacerbations 3, 4
Add ipratropium bromide 500 mcg to the albuterol nebulizer treatments if not improving after initial doses, as recommended by the Thorax guidelines 3, 4

Antibiotics have no role unless bacterial infection is confirmed—post-infectious cough is typically not bacterial, according to the Praxis Medical Insights 5, 6
Complete cough resolution requires up to 8 weeks of inhaled corticosteroid therapy, even though partial improvement occurs after 1 week, as stated by the Praxis Medical Insights 1

Consider short course of prednisone 30-40 mg daily for 5-7 days if Medrol Pak insufficient, as recommended by the Praxis Medical Insights 5, 6
Obtain chest radiograph to rule out pneumonia, masses, or other pathology, according to the Praxis Medical Insights 6
Reassess for asthma exacerbation versus post-infectious bronchial hyperresponsiveness, as recommended by the Praxis Medical Insights 5, 6